Apitolisib (GDC-0980) | 
    |
| Synonyms: (S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one | |
| Cat. No.: A64400 | CAS No.: 1032754-93-0 | 
| MDL.: | Formula: C23H30N8O3S | 
| F.W.498.6 | Purity: 99% | 
| Storage: | |
|   | |
             | Catalog Number: | A64400 | CAS No.: | 1032754-93-0 | |
| MDL: | Formula: | C23H30N8O3S | ||
| F.W.: | 498.6 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO | Stability: | ||
| Storage: | Category: | Reference Standard | ||
| Application: | GDC-0980 (RG7422) is a selective, potent, orally bioavailable inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) with in vitro IC50 of 5, 27, 7 and 14 nM for p110 a, ß, d and ? isoforms, respectively. | |||








